Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Just In
WRAL Weather Alert Day issued for Thursday due to heavy rain, chilly temperatures
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gb Sciences Inc
(OP:
GBLX
)
0.0001
UNCHANGED
Streaming Delayed Price
Updated: 2:41 PM EST, Nov 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gb Sciences Inc
Cannabis Terpenes Reduce Inflammation, Says Gb Sciences Study
November 01, 2022
Gb Sciences, Inc. (OTCQB: GBLX), a leading plant-inspired, biopharmaceutical research and drug development company, co-published a study that demonstrates the potential of selected cannabinoids and...
Via
Benzinga
New Study Shows Promising Results In Treatment Of Parkinson's Disease With Cannabinoids
October 10, 2022
Biopharmaceutical research and drug development company, Gb Sciences, Inc. (OTCQB: GBLX), co-published a study in the journal Frontiers in Pharmacology that demonstrates the efficacy of its proprietary...
Via
Benzinga
Gb Sciences To Begin Dosage Study For Cannabinoid-Containing Drug For Treatment Of Parkinson's Disease
April 12, 2022
Gb Sciences, Inc. (OTCQB: GBLX) has selected the University of Lethbridge in Canada to complete a dose range study of Gb Sciences' patent-protected formulations in a rodent model of Parkinson's...
Via
Benzinga
Marijuana And Chronic Pain: Gb Sciences' Nanoparticle Technology Boosts Efficacy Of Cannabis Terpenes
March 29, 2022
Gb Sciences, Inc.
Via
Benzinga
Not So Fast With The Cannabis-COVID Treatment: Gb Sciences And Michigan State U Researchers Clarify
February 01, 2022
Following the promising study on cannabinoids and COVID-19 published by Oregon State University, Gb Sciences, Inc.
Via
Benzinga
The Week In Cannabis: Tilray Earnings And Reactions, Weed And Covid, Italy, Marijuana At The Airport And More
January 14, 2022
Below is a recap of the main news related to the cannabis industry and markets for the week of January 10, 2022.
Via
Benzinga
Gb Sciences Leaves Cannabis Cultivation With $8M Sale Of Las Vegas Facility, Enters BioPharma Industry
January 11, 2022
Gb Sciences, Inc. (OTCQB:GBLX) announced Tuesday that it ha...
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.